News › Industry News, News

InMode Announces U.S. Patent for Fractional RF (Morpheus8)

November 11, 2020

InMode Ltd., a leading global provider of innovative medical technologies, has announced that the U.S. Patent and Trademark Office has granted to InMode Patent No. 10.799.285 covering its Morpheus8 full-body fractional radiofrequency (RF) technology.
Since its inception, InMode has invested significantly in R&D to independently develop state-of-the-art electro-surgical bi-polar radiofrequency devices, bringing to market breakthrough surgical procedures for the face, body and skin, as well as women’s health and wellness. Through its ongoing commitment to R&D, InMode has become a leader in disruptive technology and is credited with pioneering full body fractional RF technology through the commercialization of the Morpheus8 Subdermal Adipose Remodeling (SARD) device.
Read more at PR Newswire >>

Become a member

Get the tools you need to succeed in the medical spa industry.

Related
    • Bill Regulating Indiana Med Spas Has Passed: What You Need to Know and Why Collective Advocacy Matters
    • Growth, Capital and Control: Navigating Private Equity in Aesthetics
    • Med Spas Under the Microscope – The View From The FDA
    • Revance and Teoxane Announce RHA Dynamic Volume is Now Available
    • Terri Ross Consulting Appoints Cameron Hemphill as Chief Operating Officer and Strategic Advisor